clinical 1,439 words KG: ent-clin-fa0949b8 2026-03-27
kind:clinical-trialsection:clinical-trialstopic:parkinsonstopic:psptopic:lifestylestatus:observationalstate:publishedevidence:strong
Contents

Modifiable Variables in Parkinsonism Study

Knowledge Graph

Related Hypotheses (3)

Enteric Nervous System Prion-Like Propagation Blockade
Score: 0.44
Microbial Metabolite-Mediated α-Synuclein Disaggregation
Score: 0.45
Blocking AGE-RAGE Signaling in Enteric Glia to Prevent Neuro
Score: 0.42

Related Analyses (13)

4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed

Related Experiments (5)

Biomechanical Impact Profiles and Chronic Traumatic Encephal
clinical · proposed · Score: 0.40
Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri
clinical · proposed · Score: 0.40
Brainstem Circuit Modulation for PSP
clinical · proposed · Score: 0.40
cGAS-STING Pathway Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40
Non-Motor Symptom Progression in Parkinson's Disease — Mecha
clinical · proposed · Score: 0.40